Omega-3 Overview The Importance to China June 22, 2015 EPA and DHA - - PowerPoint PPT Presentation

omega 3 overview
SMART_READER_LITE
LIVE PREVIEW

Omega-3 Overview The Importance to China June 22, 2015 EPA and DHA - - PowerPoint PPT Presentation

Omega-3 Overview The Importance to China June 22, 2015 EPA and DHA omega-3s are among the most important resources in the ocean. They are a critical part of life, helping cells function and develop properly, but they primarily come from the


slide-1
SLIDE 1

June 22, 2015

Omega-3 Overview

The Importance to China

slide-2
SLIDE 2

EPA and DHA omega-3s are among the most important resources in the ocean.

They are a critical part of life, helping cells function and develop properly, but they primarily come from the marine environment.

slide-3
SLIDE 3 Source: Norwegian Scientific Committee for Food Safety

Proteins Phospholipids Fatty Acids

EPA and DHA have four known biological functions.

They are incorporated as structural components of cell membranes, increasing fluidity and allowing for proper functioning of proteins

EPA and DHA Fatty Acids

slide-4
SLIDE 4 Source: Norwegian Scientific Committee for Food Safety

Proteins Phospholipids Fatty Acids

EPA and DHA have four known biological functions.

They are oxidized to generate bioactive metabolites called eicosanoids and docosanoids that help regulate inflammation in the body

EPA and DHA Fatty Acids Eicosanoids and Docosanoids Mitochondria

slide-5
SLIDE 5 Source: Norwegian Scientific Committee for Food Safety

Proteins Phospholipids Fatty Acids

EPA and DHA have four known biological functions.

Modulate enzyme activity, including inhibiting protein kinases and preventing increases in calcium and potassium in cells

EPA and DHA Fatty Acids Eicosanoids and Docosanoids Mitochondria Enzymes

slide-6
SLIDE 6 Source: Norwegian Scientific Committee for Food Safety

Proteins Phospholipids Fatty Acids

EPA and DHA have four known biological functions.

Regulate expression of genes involved in inflammation, cell proliferation, cell death, and oxidative stress

EPA and DHA Fatty Acids Eicosanoids and Docosanoids Mitochondria DNA Enzymes

slide-7
SLIDE 7

Long-chain omega-3 deficiencies are the biggest challenges to the future of humanity.

  • Dr. Michael Crawford

“ ”

slide-8
SLIDE 8

Omega-3s are one of the most researched compounds in health and nutrition

Source: Pubmed, as of April 28, 2015

The Body of Evidence: Randomized, Controlled Trials in Humans

slide-9
SLIDE 9 Source: Pubmed as of April 28, 2015

New Scientific Papers Published on EPA and DHA, 1967-2014

Even with more than

28,000

published papers and

3,100

human clinical trials,

we are still only

beginning

to discover the

complete role EPA

and DHA play in

human health

New Human RCTs Published on EPA and DHA, 1967-2014

slide-10
SLIDE 10

Through our life stages, we can see why omega-3s may be valuable

Fetal growth Maternal stores Brain Growth Visual Development Brain Growth Regulating Inflammation Cardiovascular Protecion Neurological Cell Preservation Regulating Inflammation Cardiovascular Protection

slide-11
SLIDE 11

Double-click to enter text

1300mg 500mg 450mg

160mg

None Yet

250mg

Russia France Norway Austria, Belgium, China, Czech Republic, Denmark, Finland, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Netherlands, Portugal, Slovakia, Slovenia, Spain, Sweden, Switzerland, United Kingdom Australia, New Zealand Canada, India, Israel, Singapore, South Korea, United States

Recommended Intakes of EPA and DHA in the Top Economies of the World

Source: GOED, International Monetary Fund

China now has a recommended intake level that is in line with most

  • f the other countries of the world that have taken action
slide-12
SLIDE 12

Multiple estimates of Chinese intakes of EPA and DHA have been made, but they all agree that average intakes are quite low

Hibbeln et al, 2006 NutriCoDE, 2014 CNHS, 2002 INTERMAP study, 2007

49

mg/day

37

mg/day

250mg/day DRI

38

mg/day

20

mg/day

Estimates of Daily EPA and DHA Consumption in Chinese Adults

slide-13
SLIDE 13

Income is a factor though, which would lead one to believe that as China’s economy continues to grow, intakes will increase

Urban Rural Metropolitan Small City

56

mg/day

28

mg/day

250mg/day DRI

Daily EPA and DHA Consumption in Chinese Adults by Living Area

70

mg/day

40

mg/day

Source: Chinese Nutrition and Health Survey 2002

slide-14
SLIDE 14

The real problem is that intakes are actually declining, even though the economy has been growing

2010

41

mg/day

37

mg/day

1990

$314 $6,807

1990 2010 Daily EPA and DHA Intake in Chinese Adults Chinese per Capita GDP

Source: NutriCoDE

slide-15
SLIDE 15

Pregnant and nursing women and children should be striving for 200mg of DHA alone, but total EPA+DHA intakes could create a public health crisis

Inland Pregnant Women

30

mg/day

53

mg/day

Rural Children

Source: Lien et al, 2007; Zhang et al, 2013

100mg/day DRI

River/Lake Pregnant Women

70

mg/day

159

mg/day

River/Lake Pregnant Women

250mg/day DRI

Daily EPA and DHA Consumption in Select Chinese Populations

slide-16
SLIDE 16

Market potential in China starts with consumer awareness. Urban Chinese consumers are on the low-end of the awareness spectrum for the terms omega-3s, DHA or EPA, but there are many positives hidden in the data.

Sources: GOED Proprietary Consumer Research, Leatherhead, YouGov

Brazil United States Spain Germany U.K. Australia France Canada Italy Norway Finland Russia Sweden Iceland China Denmark Japan

98% 98% 96% 96% 95% 95% 94% 94% 93% 93% 89% 89% 88% 87% 86% 77%

50% 75% 100%

58%

slide-17
SLIDE 17

Source: GOED Proprietary Consumer Research

Market potential in China starts with consumer awareness. Low awareness of

  • mega-3s is holding back

consumption, but this means education is needed and is a powerful tool.

Unaware of omega-3s

38%

Don't know the benefits

26%

Doctor doesn't recommend

16%

Dislike Taste

16% Top Reasons Cited for Not Using Omega-3s

slide-18
SLIDE 18

China is one of the few balanced countries in the world in terms of how consumers choose to increase their omega-3 intakes

Supplements Functional Foods Seafood

China

61%

34% 31% 36%

55%

27% 27% 31%

UK France

49%

10% 27% 36%

69%

53% 39%

Brazil

17% 30%

Australia

54%

35% 23%

US

51%

35% 19% 27%

Canada

44%

22% 24% 18%

Russia

77%

18% 41% 65%

Germany

63%

33% 47% 15%

Source: GOED Proprietary Consumer Research

slide-19
SLIDE 19

Source: GOED Proprietary Consumer Research

The goal of education is to increase usage, and there are

  • pportunities to grow

the market in China with basic education

32% 37% 52% 57% Concern About Family and Heart Health to Chinese Consumer Segments

Consumers Not Knowledgeable About Omega-3 Benefits Consumers Knowledgeable About Omega-3 Benefits

Family Health Brain Health

Consumers Not Knowledgeable About Omega-3 Benefits Consumers Knowledgeable About Omega-3 Benefits

slide-20
SLIDE 20

For products targeting children and adults, we see three common areas where companies are positioning products

Heart Health Brain Health Joint Health

slide-21
SLIDE 21

The best way to identify claim opportunities is to look at whether the consumer desires the benefit and if the science supports it

Public Health Need Consumer Concern Scientific Support

Claims Opportunity

slide-22
SLIDE 22

Heart

Health

slide-23
SLIDE 23

Cardiovascular disease is the leading cause of death in China and is

  • n the rise

Source: Institute for Health Metrics Evaluation

Cardiovascular Deaths in China... ...and Disability Adjusted Life Years Lost

slide-24
SLIDE 24

However, consumer concern about heart health is relatively low in China, which reduces the ROI of heart-focused positioning

General Wellness Sleep Family’s Health Stress Energy Beauty Brain Health Heart Health 62% 28% 52% 11% 39% 22% 36% 29%

Self-Identified Health Priorities of Chinese Consumers

Source: GOED Proprietary Consumer Surveys

slide-25
SLIDE 25

The science behind omega-3s and cardiovascular disease is strong, and can support claims

Anecdotal Ideas, Expert Opinions, Editorials Case Studies Cross-sectional surveys Case Control Studies Cohort Studies RCTs Systematic Reviews & Meta Analyses of RCTs

Hierarchy of Evidence in Evidence-Based Medicine Every single meta-analysis of RCTs conducted in the last ten years has found EPA and DHA reduce coronary death risk. The latest meta-analysis included 72 RCTs,

  • ne of the largest ever conducted in

nutrition, and found EPA and DHA reduce blood pressure. Every meta-analysis of RCTs has found EPA and DHA lower triglycerides 20-40%.

  • 1. Coronary death
  • 2. Blood Pressure
  • 3. Triglycerides

Source: NIH, GOED, Miller et al 2014

slide-26
SLIDE 26

There are three common claims related to heart health used in

  • ther countries

Every single meta-analysis of RCTs conducted in the last ten years has found EPA and DHA reduce coronary death risk. The latest meta-analysis included 72 RCTs,

  • ne of the largest ever conducted in

nutrition, and found EPA and DHA reduce blood pressure. Every meta-analysis of RCTs has found EPA and DHA lower triglycerides 20-40%.

  • 1. Coronary death
  • 2. Blood Pressure
  • 3. Triglycerides

“Helps Support a Healthy Heart” “Helps Maintain Normal Blood Pressure” “Helps Maintain Healthy Triglyceride Levels”

slide-27
SLIDE 27

Brain

Health

slide-28
SLIDE 28

Alzheimer’s and dementia is on the rise in China, but pales in comparison to the impact of cardiovascular disease

Alzheimer and Dementia Death in China... ...and Disability Adjusted Life Years Lost

Source: Institute for Health Metrics Evaluation

slide-29
SLIDE 29

Consumer concern about brain health in China is higher than heart health, one of the only countries where this is true!

General Wellness Sleep Family’s Health Stress Energy Beauty Brain Health Heart Health 62% 28% 52% 11% 39% 22% 36% 29%

Self-Identified Health Priorities of Chinese Consumers

Source: GOED Proprietary Consumer Surveys

slide-30
SLIDE 30

The evidence to support brain health as we age is mixed

Anecdotal Ideas, Expert Opinions, Editorials Case Studies Cross-sectional surveys Case Control Studies Cohort Studies RCTs Systematic Reviews & Meta Analyses of RCTs

Hierarchy of Evidence in Evidence-Based Medicine No systematic review or meta-analysis has ever found that EPA/DHA can treat Alzheimer’s. A recent comprehensive meta-analysis found that >1g of DHA improved episodic, semantic, and working memory in adults, regardless of cognitive status. A few meta-analyses have seen benefits in brain function and memory in people with mild cognitive impairment without

  • dementia. More evidence is needed.
  • 1. Alzheimer’s Disease
  • 2. Memory
  • 3. Mild Cognitive Impairment

Source: NIH, GOED, Yurko-Mauro et al 2015, Mazereeuw et al 2012

slide-31
SLIDE 31

There are a few common claims related to brain health used in

  • ther countries, but companies struggle with how to keep

regulators happy in this area

No systematic review or meta-analysis has ever found that EPA/DHA can treat Alzheimer’s. A recent comprehensive meta-analysis found that >1g of DHA improved episodic, semantic, and working memory in adults, regardless of cognitive status. A few meta-analyses have seem benefits in brain function and memory in people with mild cognitive impairment without

  • dementia. More evidence is needed.
  • 1. Alzheimer’s Disease
  • 2. Memory
  • 3. Mild Cognitive Impairment

“Helps Support a Brain Health” “Helps Improve Memory”

This claim has been removed in the US due to regulatory actions, despite the strong evidence.

Source:GOED, Yurko-Mauro et al 2015, Mazereeuw et al 2012

slide-32
SLIDE 32

Joint

Health

slide-33
SLIDE 33

Arthritic diseases are also on the rise in China and cause more economic losses than brain disorders

Source: Institute for Health Metrics Evaluation

Arthritis Deaths* in China... ...and Disability Adjusted Life Years Lost

* Deaths are due to rheumatoid arthritis, as osteoarthritis is not fatal. DALYs represent both rheumatoid and osteoarthritis

slide-34
SLIDE 34

Joint health is linked to other health priorities, most of which are highly important to Chinese consumers

General Wellness Sleep Family’s Health Stress Energy Beauty Brain Health Heart Health 62% 28% 52% 11% 39% 22% 36% 29%

Self-Identified Health Priorities of Chinese Consumers

Source: GOED Proprietary Consumer Surveys

slide-35
SLIDE 35

The real question is does the science support joint health claims?

Anecdotal Ideas, Expert Opinions, Editorials Case Studies Cross-sectional surveys Case Control Studies Cohort Studies RCTs Systematic Reviews & Meta Analyses of RCTs

Hierarchy of Evidence in Evidence-Based Medicine No meta-analysis or well-designed RCT has found a beneficial improvement in

  • stearthritis from EPA and DHA.

Multiple meta-analyses have consistently found that high dosages of EPA and DHA (>2-3g/day) can help reduce the use of NSAID pain medications in rheumatoid arthritis patients.

  • 1. Osteoarthritis
  • 2. Rheumatoid Arthritis

Source: NIH, GOED

slide-36
SLIDE 36

“Helps Maintain Healthy Joints”

This claim has been scrutinized heavily in Australia, where the market declined after negative media attention about the benefits.

The most common claims about joint health are bland, but have caught regulatory scrutiny

No meta-analysis or well-designed RCT has found a beneficial improvement in

  • stearthritis from EPA and DHA.

Multiple meta-analyses have consistently found that high dosages of EPA and DHA (>2-3g/day) can help reduce the use of NSAID pain medications in rheumatoid arthritis patients.

  • 1. Osteoarthritis
  • 2. Rheumatoid Arthritis

Rheumatoid arthritis is very clearly a disease that would prevent these types of claims in most geographies.

slide-37
SLIDE 37

Summary Summary

slide-38
SLIDE 38

There are opportunities to grow the market for omega-3s in China with basic consumer education Heart health presents the strongest science opportunity, but consumers do not appear to be concerned about the problem The brain health opportunity is big, but it will be important to have sound regulatory advice